|
Valiant Laboratories Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
581.69 Cr.
|
P/BV
|
1.75
|
Book Value (Rs.)
|
61.13
|
|
52 Week High/Low (Rs.)
|
141/50
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
19/07/2025
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| No. of Equity Shares (in Lacs) | 543.13 | 434.50 | 434.50 | 325.60 |
| | | | | |
| EQUITIES AND LIABILITIES | | | | |
| SHAREHOLDER'S FUNDS | | | | |
| Equity Share Capital | 54.31 | 43.45 | 43.45 | 32.56 |
| Total Share Capital | 54.31 | 43.45 | 43.45 | 32.56 |
| | | | | |
| Reserves and Surplus | 256.57 | 190.86 | 193.41 | 67.93 |
| Total Reserves and Surplus | 256.57 | 190.86 | 193.41 | 67.93 |
| Total Shareholders Funds | 310.89 | 234.31 | 236.86 | 100.49 |
| | | | | |
| NON-CURRENT LIABILITIES | | | | |
| Long Term Borrowings | 28.09 | 104.35 | 74.66 | 59.40 |
| Deferred Tax Liabilities [Net] | 3.65 | 1.24 | 0.62 | 0.67 |
| Other Long Term Liabilities | 1.76 | 1.21 | 1.39 | 1.60 |
| Long Term Provisions | 0.15 | 0.13 | 0.08 | 0.08 |
| Total Non-Current Liabilities | 33.65 | 106.93 | 76.75 | 61.75 |
| | | | | |
| CURRENT LIABILITIES | | | | |
| Short Term Borrowings | 16.86 | 16.86 | 1.39 | 0.00 |
| Trade Payables | 94.02 | 40.72 | 25.93 | 47.30 |
| Other Current Liabilities | 8.25 | 1.84 | 1.65 | 3.31 |
| Short Term Provisions | 0.32 | 0.20 | 0.12 | 0.12 |
| Total Current Liabilities | 119.45 | 59.62 | 29.08 | 50.73 |
| | | | | |
| Total Capital And Liabilities | 463.98 | 400.86 | 342.69 | 212.97 |
| | | | | |
| ASSETS | | | | |
| NON-CURRENT ASSETS | | | | |
| Tangible Assets | 227.01 | 48.33 | 50.05 | 48.12 |
| Intangible Assets | 0.11 | 0.11 | 0.00 | 0.00 |
| Capital Work-In-Progress | 6.08 | 155.78 | 42.65 | 0.68 |
| Fixed Assets | 233.21 | 204.22 | 92.70 | 48.80 |
| Other Non-Current Assets | 2.44 | 4.02 | 24.44 | 13.59 |
| Total Non-Current Assets | 235.65 | 208.24 | 117.14 | 62.39 |
| | | | | |
| | | | | |
| CURRENT ASSETS | | | | |
| Current Investments | 26.09 | 0.00 | 37.61 | 34.02 |
| Inventories | 45.43 | 3.99 | 10.02 | 13.04 |
| Trade Receivables | 93.56 | 72.12 | 45.73 | 88.57 |
| Cash And Cash Equivalents | 7.06 | 75.99 | 106.21 | 1.34 |
| Short Term Loans And Advances | 0.04 | 0.06 | 0.03 | 0.07 |
| OtherCurrentAssets | 56.14 | 40.45 | 25.95 | 13.54 |
| Total Current Assets | 228.32 | 192.62 | 225.54 | 150.58 |
| | | | | |
| Total Assets | 463.98 | 400.86 | 342.69 | 212.97 |
| | | | | |
| OTHER INFORMATION | | | | |
| | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | |
| Contingent Liabilities | 67.08 | 76.08 | 16.73 | 0.42 |
| | | | | |
| BONUS DETAILS | | | | |
| Bonus Equity Share Capital | 16.28 | 16.28 | 16.28 | 16.28 |
| | | | | |
| CURRENT INVESTMENTS | | | | |
| Current Investments Quoted Market Value | 26.09 | 0.00 | 0.00 | 0.00 |
